Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies
Jennifer K Logan, Soroush Rais-Bahrami, Baris Turkbey, Andrew Gomella, Hayet Amalou, Peter L Choyke, Bradford J Wood, Peter A Pinto, Jennifer K Logan, Soroush Rais-Bahrami, Baris Turkbey, Andrew Gomella, Hayet Amalou, Peter L Choyke, Bradford J Wood, Peter A Pinto
Abstract
Prostate MRI is currently the best diagnostic imaging method for detecting PCa. Magnetic resonance imaging (MRI)/ultrasonography (US) fusion allows the sensitivity and specificity of MRI to be combined with the real-time capabilities of transrectal ultrasonography (TRUS). Multiple approaches and techniques exist for MRI/US fusion and include direct 'in bore' MRI biopsies, cognitive fusion, and MRI/US fusion via software-based image coregistration platforms.
Keywords: MRI/US fusion; MRI/US fusion platforms; prostate MRI; targeted biopsy.
© 2013 The Authors. BJU International © 2013 BJU International.
Figures
Source: PubMed